CAS Number:
183449-57-2
Purity:
Peak Area by HPLC ≥95%
Molecular Weight:
4310.2
Product Description:
This is one of the predominant amyloid peptide structures deposited in human brain of Alzheimer’s disease and Down’s syndrome patients. N-terminally truncated pyroglutamate-modified beta-Amyloid forms such as Aβ(3-42) and Aβ (11- 42) have been described as major compounds in the senile plaques. Pyro-Glu modified beta-Amyloid forms are more resistant to degradation, show higher toxicity and have increased aggregation propensity compared to non-modified beta-Amyloid.
Storage Temperature:
-20°C